title: Fanconi anemia proteins stabilize replication forks.
abstract: Fanconi anemia (FA) is a recessive genetic disorder characterized by hypersensitivity to crosslinking agents that has been attributed to defects in DNA repair and/or replication. FANCD2 and the FA core complex bind to chromatin during DNA replication; however, the role of FA proteins during replication is unknown. Using Xenopus cell-free extracts, we show that FANCL depletion results in defective DNA replication restart following treatment with camptothecin, a drug that results in DSBs during DNA replication. This defect is more pronounced following treatment with mitomycin C, presumably because of an additional role of the FA pathway in DNA crosslink repair. Moreover, we show that chromatin binding of FA core complex proteins during DNA replication follows origin assembly and origin firing and is dependent on the binding of RPA to ssDNA while FANCD2 additionally requires ATR, consistent with FA proteins acting at replication forks. Together, our data suggest that FA proteins play a role in replication restart at collapsed replication forks.
authors.affiliation: Institute for Cancer Genetics, Columbia University, New York, NY 10032, USA.
authors.forename: Lily Chien
authors.initials: LC
authors.lastname: Wang
authors.forename: Stacie
authors.initials: S
authors.lastname: Stone
authors.forename: Maureen Elizabeth
authors.initials: ME
authors.lastname: Hoatlin
authors.forename: Jean
authors.initials: J
authors.lastname: Gautier
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology; D016590:Aphidicolin / Q000494:pharmacology; D064007:Ataxia Telangiectasia Mutated Proteins; D002166:Camptothecin / Q000494:pharmacology; D018797:Cell Cycle Proteins / Q000378:metabolism; D002467:Cell Nucleus / Q000378:metabolism; D002474:Cell-Free System; D002843:Chromatin / Q000378:metabolism*; D004249:DNA Damage; D004260:DNA Repair; D004261:DNA Replication; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005199:Fanconi Anemia; D052236:Fanconi Anemia Complementation Group D2 Protein / Q000502:physiology*; D052240:Fanconi Anemia Complementation Group L Protein / Q000502:physiology*; D016685:Mitomycin / Q000494:pharmacology; D010766:Phosphorylation; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D029867:Xenopus Proteins / Q000378:metabolism; D014982:Xenopus laevis
chemical_list: D000903:Antibiotics, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D018797:Cell Cycle Proteins; D002843:Chromatin; D004791:Enzyme Inhibitors; D052236:Fanconi Anemia Complementation Group D2 Protein; D029867:Xenopus Proteins; D016590:Aphidicolin; D016685:Mitomycin; D052240:Fanconi Anemia Complementation Group L Protein; C576898:Atr protein, Xenopus; D064007:Ataxia Telangiectasia Mutated Proteins; D017346:Protein Serine-Threonine Kinases; D002166:Camptothecin
references.citation: Nature. 2001 Aug 2;412(6846):553-7
references.pmid: 11484057
references.citation: J Biol Chem. 2004 Oct 29;279(44):46035-45
references.pmid: 15299017
references.citation: Nat Rev Genet. 2007 Oct;8(10):735-48
references.pmid: 17768402
references.citation: Hum Mol Genet. 2002 Oct 1;11(21):2591-7
references.pmid: 12354784
references.citation: Hum Mol Genet. 2004 Jun 15;13(12):1241-8
references.pmid: 15115758
references.citation: Blood. 1988 Jul;72(1):366-7
references.pmid: 3291985
references.citation: Blood. 2004 Apr 1;103(7):2498-503
references.pmid: 14630800
references.citation: Mol Cell. 2007 Feb 9;25(3):331-43
references.pmid: 17289582
references.citation: EMBO Rep. 2007 Apr;8(4):346-53
references.pmid: 17401409
references.citation: Cell. 2007 Apr 20;129(2):289-301
references.pmid: 17412408
references.citation: J Cell Biol. 2003 Oct 27;163(2):245-55
references.pmid: 14581453
references.citation: Mol Genet Metab. 2001 Dec;74(4):403-12
references.pmid: 11749045
references.citation: Nat Genet. 2005 Sep;37(9):958-63
references.pmid: 16116422
references.citation: Cell Oncol. 2007;29(3):211-8
references.pmid: 17452773
references.citation: Nat Genet. 2007 Feb;39(2):159-61
references.pmid: 17200672
references.citation: Science. 2007 May 25;316(5828):1160-6
references.pmid: 17525332
references.citation: Blood. 2005 Jan 15;105(2):759-66
references.pmid: 15256425
references.citation: Science. 2002 Jul 26;297(5581):602-6
references.pmid: 12142538
references.citation: Mol Cancer Ther. 2006 Apr;5(4):952-61
references.pmid: 16648566
references.citation: EMBO J. 2004 Aug 4;23(15):3154-63
references.pmid: 15257300
references.citation: Mol Cell. 2001 Feb;7(2):249-62
references.pmid: 11239454
references.citation: Blood. 2005 Feb 1;105(3):1003-9
references.pmid: 15454491
references.citation: Science. 2003 Jun 6;300(5625):1542-8
references.pmid: 12791985
references.citation: Cancer Cell. 2005 Sep;8(3):255-65
references.pmid: 16153896
references.citation: Nat Cell Biol. 2004 Jul;6(7):648-55
references.pmid: 15220931
references.citation: Blood. 1987 Jun;69(6):1637-41
references.pmid: 3107630
references.citation: Nat Genet. 2004 Nov;36(11):1219-24
references.pmid: 15502827
references.citation: Mol Cell Biol. 2004 Jul;24(13):5850-62
references.pmid: 15199141
references.citation: Nat Struct Mol Biol. 2007 Jun;14(6):564-7
references.pmid: 17460694
references.citation: Nat Genet. 2003 Oct;35(2):165-70
references.pmid: 12973351
references.citation: Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13085-90
references.pmid: 9789045
references.citation: Nat Genet. 2007 Feb;39(2):162-4
references.pmid: 17200671
references.citation: Cell Cycle. 2004 Jun;3(6):698-700
references.pmid: 15136767
references.citation: EMBO J. 2005 Dec 21;24(24):4334-44
references.pmid: 16369567
references.citation: Cell. 2001 Apr 6;105(1):149-60
references.pmid: 11301010
references.citation: Environ Mol Mutagen. 2005 Mar-Apr;45(2-3):128-42
references.pmid: 15668941
references.citation: Mol Cell Biol. 2007 Jun;27(12):4283-92
references.pmid: 17420278
references.citation: Genes Dev. 2005 Dec 15;19(24):2925-40
references.pmid: 16357213
references.citation: Blood. 2007 Oct 1;110(7):2390-8
references.pmid: 17596542
references.citation: Mol Cell Biol. 2006 Jan;26(2):425-37
references.pmid: 16382135
references.citation: Genes Cells. 2007 Oct;12(10):1111-22
references.pmid: 17903171
references.citation: Science. 2002 Jul 26;297(5581):606-9
references.pmid: 12065746
references.citation: Mol Cell. 2001 Jul;8(1):137-47
references.pmid: 11511367
references.citation: Genes Cells. 2007 Jul;12(7):841-51
references.pmid: 17584296
references.citation: Mol Cell Biol. 2006 Sep;26(18):7005-15
references.pmid: 16943440
references.citation: Annu Rev Biochem. 2002;71:333-74
references.pmid: 12045100
references.citation: Mol Cell Biol. 2007 Apr;27(8):3098-108
references.pmid: 17296736
references.citation: Genes Dev. 2006 Jan 15;20(2):159-73
references.pmid: 16384935
references.citation: Genes Dev. 2001 Sep 1;15(17):2177-96
references.pmid: 11544175
references.citation: Nature. 2001 Aug 2;412(6846):557-61
references.pmid: 11484058
references.citation: Ann N Y Acad Sci. 2000;922:1-10
references.pmid: 11193884
references.citation: Biochimie. 2005 Jul;87(7):647-58
references.pmid: 15935541
references.citation: Mol Cell Biol. 2007 Dec;27(24):8421-30
references.pmid: 17938197
references.citation: Hum Genet. 1985;71(3):206-10
references.pmid: 4065892
references.citation: EMBO J. 2007 Apr 18;26(8):2104-14
references.pmid: 17396147
references.citation: EMBO J. 2006 Apr 19;25(8):1764-74
references.pmid: 16601701